OneChain Immunotherapeutics
Company

OneChain Immunotherapeutics

Biotechnology Research Jobs 19 employees
Employees
19
Contacts
2
Emails
2

OneChain Immunotherapeutics Overview

Headquarters
Jobs
Industry
Biotechnology Research
Employees
19
Founded
2020
Funding
7.3M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About OneChain Immunotherapeutics

OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.

OneChain Immunotherapeutics Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage

OneChain Immunotherapeutics Org Chart

Sample employees and titles
Name Title Contact
Barbara Krebs-Pohl Biotech Cxo, Non-executive Director
View
Wilmar Castillo Avila Senior Project Manager En Onechain
Email
Stefanos Theoharis CEO of Onechain Immunotherapeutics
Email

Employees by Management Level

Executive 1 profile
Director 1 profile
Manager 1 profile

Compare Similar Companies to OneChain Immunotherapeutics